{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:38:22Z","timestamp":1793039902460,"version":"4.5.0"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Chronic hepatitis B virus (HBV) infection remains to be a substantial global burden, especially for end-stage liver diseases. It is well accepted that HBV-specific T and B cells are essential for controlling HBV infection. Toll-like receptors (TLRs) represent one of the major first-line antiviral defenses through intracellular signaling pathways that induce antiviral inflammatory cytokines and interferons, thereby shaping adaptive immunity. However, HBV has evolved strategies to counter TLR responses by suppressing the expression of TLRs and blocking the downstream signaling pathways, thus limiting HBV-specific adaptive immunity and facilitating viral persistence. Recent studies have stated that stimulation of the TLR signaling pathway by different TLR agonists strengthens host innate immune responses and results in suppression of HBV replication. In this review, we will discuss how TLR-mediated responses shape HBV-specific adaptive immunity as demonstrated in different experimental models. This information may provide important insight for HBV functional cure based on TLR agonists as immunomodulators.<\/jats:p>","DOI":"10.3389\/fimmu.2022.965018","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T02:56:25Z","timestamp":1659063385000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection"],"prefix":"10.3389","volume":"13","author":[{"given":"Yanqin","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengji","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6728a2","article-title":"Access to treatment for hepatitis b virus infection - worldwide, 2016","volume":"67","author":"Hutin","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis b virus infection","volume":"77","author":"Thimme","year":"2003","journal-title":"J Virol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.01.026","article-title":"Adaptive immunity in HBV infection","volume":"64","author":"Bertoletti","year":"2016","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI121957","article-title":"PD-1 blockade partially recovers dysfunctional virus-specific b cells in chronic hepatitis b infection","volume":"128","author":"Salimzadeh","year":"2018","journal-title":"J Clin Invest"},{"key":"B5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.5009\/gnl17233","article-title":"Immunotherapy for chronic hepatitis b virus infection","volume":"12","author":"Bertoletti","year":"2018","journal-title":"Gut Liver"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00430-014-0370-1","article-title":"Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis b virus (HBV) infection","volume":"204","author":"Zhang","year":"2015","journal-title":"Med Microbiol Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2014.112","article-title":"Contribution of toll-like receptors to the control of hepatitis b virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses","volume":"12","author":"Ma","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis b virus infection","volume":"101","author":"Wieland","year":"2004","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.163600","article-title":"Early kinetics of innate and adaptive immune responses during hepatitis b virus infection","volume":"58","author":"Fisicaro","year":"2009","journal-title":"GUT"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.06.054","article-title":"Temporal analysis of early immune responses in patients with acute hepatitis b virus infection","volume":"137","author":"Dunn","year":"2009","journal-title":"Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.01.034","article-title":"Hepatitis b virus does not interfere with innate immune responses in the human liver","volume":"154","author":"Suslov","year":"2018","journal-title":"Gastroenterology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23226","article-title":"Not interferon, but interleukin-6 controls early gene expression in hepatitis b virus infection","volume":"50","author":"Hosel","year":"2009","journal-title":"Hepatology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31112","article-title":"Hepatitis b virus particles activate toll-like receptor 2 signaling initially upon infection of primary human hepatocytes","volume":"72","author":"Zhang","year":"2020","journal-title":"Hepatology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41419-020-03284-1","article-title":"Hepatitis b virus particles activate b cells through the TLR2-MyD88-mTOR axis","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death Dis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(02)02243-X","article-title":"Recombinant HBsAg, an apoptotic-like lipoprotein, interferes with the LPS-induced activation of ERK-1\/2 and JNK-1\/2 in monocytes","volume":"297","author":"Vanlandschoot","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02903-15","article-title":"Hepatitis b virus surface antigen activates myeloid dendritic cells via a soluble CD14-dependent mechanism","volume":"90","author":"van Montfoort","year":"2016","journal-title":"J Virol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/09674845.2018.1547179","article-title":"TLR3 and TLR4 SNP variants in the liver disease resulting from hepatitis b virus and hepatitis c virus infection","volume":"76","author":"Sghaier","year":"2019","journal-title":"Br J BioMed Sci"},{"key":"B22","doi-asserted-by":"publisher","first-page":"12737","DOI":"10.1038\/s41598-018-31065-6","article-title":"Polymorphisms in the toll-like receptor 3 (TLR3) gene are associated with the natural course of hepatitis b virus infection in Caucasian population","volume":"8","author":"Fischer","year":"2018","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12879-018-2943-x","article-title":"Correlation between polymorphisms in toll-like receptor genes and the activity of hepatitis b virus among treatment-naive patients: a case-control study in a han Chinese population","volume":"18","author":"Lin","year":"2018","journal-title":"BMC Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/vaccines6010006","article-title":"Interaction between hepatitis b virus and toll-like receptors: Current status and potential therapeutic use for chronic hepatitis b","volume":"6","author":"Ma","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.04.006","article-title":"Expression profiles and function of toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis b patients","volume":"128","author":"Chen","year":"2008","journal-title":"Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2630","article-title":"Reduced toll-like receptor 3 expression in chronic hepatitis b patients and its restoration by interferon therapy","volume":"18","author":"Huang","year":"2013","journal-title":"Antivir Ther"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2016.12.006","article-title":"Impaired expression and function of TLR8 in chronic HBV infection and its association with treatment responses during peg-IFN-alpha-2a antiviral therapy","volume":"41","author":"Deng","year":"2017","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745-7254.2008.00711.x","article-title":"Toll-like receptor 7 and 9 expression in peripheral blood mononuclear cells from patients with chronic hepatitis b and related hepatocellular carcinoma","volume":"29","author":"Xu","year":"2008","journal-title":"Acta Pharmacol Sin"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0026315","article-title":"Hepatitis b virus impairs TLR9 expression and function in plasmacytoid dendritic cells","volume":"6","author":"Vincent","year":"2011","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2013.09.015","article-title":"Decreased expression of toll like receptor signaling molecules in chronic HBV infected patients","volume":"75","author":"Momeni","year":"2014","journal-title":"Hum Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12477","article-title":"Toll-IL1 receptor-mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated-IFN in HBeAg-positive CHB patients","volume":"23","author":"Visvanathan","year":"2016","journal-title":"J Viral Hepat"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2012.04.013","article-title":"Pattern recognition receptor responses in children with chronic hepatitis b virus infection","volume":"54","author":"Heiberg","year":"2012","journal-title":"J Clin Virol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00011-012-0493-z","article-title":"Downregulation of TLR7\/9 leads to deficient production of IFN-alpha from plasmacytoid dendritic cells in chronic hepatitis b","volume":"61","author":"Xu","year":"2012","journal-title":"Inflammation Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2009.04.031","article-title":"HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells","volume":"46","author":"Xu","year":"2009","journal-title":"Mol Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.618196","article-title":"Hepatitis b surface antigen suppresses the activation of nuclear factor kappa b pathway via interaction with the TAK1-TAB2 complex","volume":"12","author":"Deng","year":"2021","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.12.042","article-title":"The hepatitis b e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway","volume":"55","author":"Lang","year":"2011","journal-title":"J Hepatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091658","article-title":"Hepatitis b virus polymerase suppresses NF-kappaB signaling by inhibiting the activity of IKKs via interaction with Hsp90beta","volume":"9","author":"Liu","year":"2014","journal-title":"PloS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21897","article-title":"Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice","volume":"46","author":"Wu","year":"2007","journal-title":"Hepatology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22751","article-title":"Hepatitis b virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells","volume":"49","author":"Wu","year":"2009","journal-title":"Hepatology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12216","article-title":"Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis b virus surface antigen","volume":"21","author":"Jiang","year":"2014","journal-title":"J Viral Hepatitis"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015324","article-title":"Hepatitis b virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function","volume":"6","author":"Woltman","year":"2011","journal-title":"PloS One"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20366","article-title":"Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis b","volume":"40","author":"van der Molen","year":"2004","journal-title":"Hepatology"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2021.0040","article-title":"Influence of pattern recognition receptor ligands on induction of innate immunity and control of hepatitis b virus infection","volume":"34","author":"Asadi-Asadabad","year":"2021","journal-title":"Viral Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.1038\/s41598-018-23525-w","article-title":"Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes","volume":"8","author":"Lucifora","year":"2018","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02844-06","article-title":"Characterization of hepatitis b virus (HBV)-specific T-cell dysfunction in chronic HBV infection","volume":"81","author":"Boni","year":"2007","journal-title":"J Virol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1084\/jem.20121172","article-title":"Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell\u2013mediated deletion","volume":"210","author":"Peppa","year":"2013","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2567.2009.03179.x","article-title":"Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific","volume":"129","author":"Wu","year":"2010","journal-title":"Immunology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.11.7269-7272.2005","article-title":"Toll-like receptor signaling inhibits hepatitis b virus replication in vivo","volume":"79","author":"Isogawa","year":"2005","journal-title":"J Virol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2015.00024","article-title":"IL-6 plays a crucial role in HBV infection","volume":"3","author":"Lan","year":"2015","journal-title":"J Clin Transl Hepatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003208","article-title":"The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells","volume":"9","author":"Schurich","year":"2013","journal-title":"PloS Pathog"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.21.10702-10707.2002","article-title":"Interleukin-18 inhibits hepatitis b virus replication in the livers of transgenic mice","volume":"76","author":"Kimura","year":"2002","journal-title":"J Virol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900065","article-title":"TLR2 stimulation increases cellular metabolism in CD8(+) T cells and thereby enhances CD8(+) T cell activation, function, and antiviral activity","volume":"203","author":"Zhang","year":"2019","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0400171101","article-title":"TLR2 is expressed on activated T cells as a costimulatory receptor","volume":"101","author":"Komai-Koma","year":"2004","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200636181","article-title":"TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation","volume":"36","author":"Cottalorda","year":"2006","journal-title":"Eur J Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-268169","article-title":"When toll-like receptor and T-cell receptor signals collide: a mechanism for enhanced CD8 T-cell effector function","volume":"116","author":"Geng","year":"2010","journal-title":"Blood"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02191","article-title":"Toll-like receptor 7 activation enhances CD8+ T cell effector functions by promoting cellular glycolysis","volume":"10","author":"Li","year":"2019","journal-title":"Front Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.12.8708","article-title":"Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor","volume":"177","author":"Tabiasco","year":"2006","journal-title":"J Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199904)29:04<1209::AID-IMMU1209>3.0.CO;2-J","article-title":"CpG-oligodeoxynucleotides co-stimulate primary T cells in the absence of antigen-presenting cells","volume":"29","author":"Bendigs","year":"1999","journal-title":"Eur J Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.2741\/3279","article-title":"The divergence and interplay between pDC and mDC in humans","volume":"14","author":"Kadowaki","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2007","article-title":"Immune function of plasmacytoid dendritic cells, natural killer cells, and their crosstalk in HBV infection","volume":"28","author":"Golsaz-Shirazi","year":"2018","journal-title":"Rev Med Virol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2009.02.008","article-title":"Patients with chronic hepatitis b infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9","volume":"11","author":"Xie","year":"2009","journal-title":"Microbes Infect"},{"key":"B62","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/hep.30637","article-title":"Characteristics of impaired dendritic cell function in patients with hepatitis b virus infection","volume":"70","author":"Yonejima","year":"2019","journal-title":"Hepatology"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-016-9763-0","article-title":"Functionally aberrant dendritic cell subsets and expression of DC-SIGN differentiate acute from chronic HBV infection","volume":"10","author":"Sukriti","year":"2016","journal-title":"Hepatol Int"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2004.00497.x","article-title":"Selective functional deficit in dendritic cell\u2013T cell interaction is a crucial mechanism in chronic hepatitis b virus infection","volume":"11","author":"Zheng","year":"2004","journal-title":"J Viral Hepat"},{"key":"B65","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/j.1365-2249.2007.03547.x","article-title":"Peripheral blood dendritic cells are phenotypically and functionally intact in chronic hepatitis b virus (HBV) infection","volume":"151","author":"Tavakoli","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737995","article-title":"Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation","volume":"38","author":"Bijker","year":"2008","journal-title":"Eur J Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix614","article-title":"HBV-derived synthetic long peptide can boost CD4+ and CD8+ T-cell responses in chronic HBV patients ex vivo","volume":"217","author":"Dou","year":"2018","journal-title":"J Infect Dis"},{"key":"B68","doi-asserted-by":"publisher","first-page":"104746","DOI":"10.1016\/j.antiviral.2020.104746","article-title":"Design o TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients","volume":"178","author":"Dou","year":"2020","journal-title":"Antiviral Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00920-18","article-title":"Intrahepatic cross-presentation and hepatocellular antigen presentation play distinct roles in the induction of hepatitis b virus-specific CD8(+) T cell responses","volume":"92","author":"Murata","year":"2018","journal-title":"J Virol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13251","article-title":"TLR5 activation in hepatocytes alleviates the functional suppression of intrahepatic CD8(+) T cells","volume":"161","author":"Yan","year":"2020","journal-title":"Immunology"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s00430-014-0371-0","article-title":"The role of hepatic immune regulation in systemic immunity to viral infection","volume":"204","author":"Knolle","year":"2015","journal-title":"Med Microbiol Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1159\/000329801","article-title":"Mechanisms balancing tolerance and immunity in the liver","volume":"29","author":"Bottcher","year":"2011","journal-title":"Dig Dis"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700921","article-title":"Local stimulation of liver sinusoidal endothelial cells with a NOD1 agonist activates T cells and suppresses hepatitis b virus replication in mice","volume":"200","author":"Huang","year":"2018","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301262","article-title":"TLR1\/2 ligand-stimulated mouse liver endothelial cells secrete IL-12 and trigger CD8+ T cell immunity in vitro","volume":"191","author":"Liu","year":"2013","journal-title":"J Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.02.008","article-title":"Liver-primed memory T cells generated under noninflammatory conditions provide anti-infectious immunity","volume":"3","author":"Bottcher","year":"2013","journal-title":"Cell Rep"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.17219\/acem\/62759","article-title":"Kupffer cells in immune activation and tolerance toward HBV\/HCV infection","volume":"26","author":"Yuan","year":"2017","journal-title":"Adv Clin Exp Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700540","article-title":"TLR2 stimulation strengthens intrahepatic myeloid-derived cell-mediated T cell tolerance through inducing kupffer cell expansion and IL-10 production","volume":"200","author":"Liu","year":"2018","journal-title":"J Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500839","article-title":"Kupffer cells support hepatitis b virus-mediated CD8+ T cell exhaustion via hepatitis b core antigen-TLR2 interactions in mice","volume":"195","author":"Li","year":"2015","journal-title":"J Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2001.29594","article-title":"Kupffer cell-mediated recruitment of rat dendritic cells to the liver: roles of n-acetylgalactosamine-specific sugar receptors","volume":"121","author":"Uwatoku","year":"2001","journal-title":"Gastroenterology"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24508","article-title":"Cross-presentation of antigen by diverse subsets of murine liver cells","volume":"54","author":"Ebrahimkhani","year":"2011","journal-title":"Hepatology"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22395","article-title":"Mechanism of T cell tolerance induction by murine hepatic kupffer cells","volume":"48","author":"You","year":"2008","journal-title":"Hepatology"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2021.05.005","article-title":"Identification of a kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming","volume":"54","author":"De Simone","year":"2021","journal-title":"Immunity"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.766534","article-title":"In vivo mouse models for hepatitis b virus infection and their application","volume":"12","author":"Du","year":"2021","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00996-14","article-title":"Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis b virus in a hydrodynamic injection mouse model","volume":"88","author":"Wu","year":"2014","journal-title":"J Virol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00034-21","article-title":"Simultaneous or prior activation of intrahepatic type I interferon signaling leads to hepatitis b virus persistence in a mouse model","volume":"95","author":"Zou","year":"2021","journal-title":"J Virol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.actbio.2021.01.045","article-title":"Delivery of toll-like receptor 3 ligand poly(I:C) to the liver by calcium phosphate nanoparticles conjugated with an F4\/80 antibody exerts an anti-hepatitis b virus effect in a mouse model","volume":"133","author":"Du","year":"2021","journal-title":"Acta Biomater"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01495","article-title":"Pre-activation of toll-like receptor 2 enhances CD8(+) T-cell responses and accelerates hepatitis b virus clearance in the mouse models","volume":"9","author":"Lin","year":"2018","journal-title":"Front Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2573","article-title":"Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection","volume":"14","author":"Huang","year":"2013","journal-title":"Nat Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/0192-0561(94)90015-9","article-title":"Efficacy of polyadenylic.polyuridylic acid in the treatment of chronic active hepatitis b","volume":"16","author":"Hahm","year":"1994","journal-title":"Int J Immunopharmacol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12942","article-title":"Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis b who are not currently on antiviral treatment","volume":"25","author":"Agarwal","year":"2018","journal-title":"J Viral Hepat"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.037","article-title":"The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis b virus infection","volume":"63","author":"Gane","year":"2015","journal-title":"J Hepatol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.10.027","article-title":"Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis b","volume":"68","author":"Janssen","year":"2018","journal-title":"J Hepatol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.01.030","article-title":"TLR7 agonist increases responses of hepatitis b virus-specific T cells and natural killer cells in patients with chronic hepatitis b treated with Nucleos(T)Ide analogues","volume":"154","author":"Boni","year":"2018","journal-title":"Gastroenterology"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004210","article-title":"Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver","volume":"10","author":"Jo","year":"2014","journal-title":"PloS Pathog"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c00100","article-title":"Discovery of GS-9688 (Selgantolimod) as a potent and selective oral toll-like receptor 8 agonist for the treatment of chronic hepatitis b","volume":"63","author":"Mackman","year":"2020","journal-title":"J Med Chem"},{"key":"B96","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/hep.31695","article-title":"Therapeutic potential of TLR8 agonist GS-9688 (Selgantolimod) in chronic hepatitis b: Remodeling of antiviral and regulatory mediators","volume":"74","author":"Amin","year":"2021","journal-title":"Hepatology"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.735913","article-title":"Follicular helper T (TFH) cell targeting by TLR8 signaling for improving HBsAg-specific b cell response in chronic hepatitis b patients","volume":"12","author":"Ayithan","year":"2021","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.965018\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T02:56:28Z","timestamp":1659063388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.965018\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":97,"alternative-id":["10.3389\/fimmu.2022.965018"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.965018","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]},"article-number":"965018"}}